Lupa Kata Sandi? Klik di Sini

atau Masuk melalui

Belum Memiliki Akun Daftar di Sini


atau Daftar melalui

Sudah Memiliki Akun Masuk di Sini

Konfirmasi Email

Kami telah mengirimkan link aktivasi melalui email ke rudihamdani@gmail.com.

Klik link aktivasi dan dapatkan akses membaca 2 artikel gratis non Laput di koran dan Majalah Tempo

Jika Anda tidak menerima email,
Kirimkan Lagi Sekarang

3 Emergency Drugs to Treat COVID-19 Patients

27 May 2020 17:04 WIB

TEMPO.CO, JakartaMonths after the coronavirus (COVID-19) spread worldwide, there have yet been any medicines or vaccines found by global health agencies. However, there are a number of drugs available in the market that are believed to be able to target the SARS-CoV-2, which causes COVID-19. 

The Indonesian Food and Drug Monitoring Agency (BPOM) in its official guide book entitled “Everything COVID-19: Preventing the virus and maintaining good health” describes three approved drugs that can be used to treat patients under emergency pandemic circumstances:

1. Chloroquine

This drug is among many potent drugs approved by the BPOM to treat adult or teenage COVID-19 patients, under emergency conditions. The use of this drug needs to be under a doctor’s close monitoring due to the side effects chloroquine can cause, which include stomachaches and headaches. Consulting doctors is highly recommended once a patient taking this drug experiences heartbeat irregularities, vision problems, hearing difficulties, and muscle weaknesses.

2. Hydroxychloroquine

This is also one of the many potent drugs that need to be under expert medical monitoring for its use. The HydroxyChloroquine is generally used to treat Systemic Lupus Erythematosus (SLE). The BPOM passed the use of this drug only under emergency situations for adult and teenage COVID-19 sufferers. The side effects include nausea and vomiting. 

3. Favipiravir

This hard drug is also approved by the BPOM to be used on adult COVID-19 patient treatments. However, the health agency strongly recommends against female patients who are pregnant or are breastfeeding. The side effects caused by this drug range from diarrhea, nausea, vomiting, stomachache, stomach inflammation, and peptic ulcers. 

SARAH ERVINA DARA SIYAHAILATUA



Indonesian Customs Destroys 1 Ton of Milk Buns from Thailand

17 hari lalu

Indonesian Customs Destroys 1 Ton of Milk Buns from Thailand

The Customs and Excise Office at Soekarno-Hatta Airport together with BPOM destroyed 2,564 packs of milk buns from Thailand.


Indonesia's Aviation Sector to Recover 100% in 2024 Post COVID-19 Pandemic

20 hari lalu

Indonesia's Aviation Sector to Recover 100% in 2024 Post COVID-19 Pandemic

The recovery in the aviation sector post-COVID-19 pandemic has reached 83 percent.


How India's COVID Lockdowns Impacted Menstrual Health

33 hari lalu

How India's COVID Lockdowns Impacted Menstrual Health

Limited access to period products during India's COVID lockdown highlighted how far public health initiatives have to go when it comes to menstruation


How Do You Eliminate or Eradicate an Infectious Disease?

33 hari lalu

How Do You Eliminate or Eradicate an Infectious Disease?

The COVID-19 pandemic gave the world a crash course in epidemiology and showed in real time how an infectious disease can spread or be contained.


Why Have Efforts to Eradicate TB Been So Slow?

36 hari lalu

Why Have Efforts to Eradicate TB Been So Slow?

Tuberculosis (TB) is one of the world's most deadly infectious diseases - but the COVID-19 pandemic dramatically slowed efforts to eliminate it.


BPOM Estimated Antimicrobial Resistance to Cause 10 Million Deaths by 2050

51 hari lalu

BPOM Estimated Antimicrobial Resistance to Cause 10 Million Deaths by 2050

BPOM estimated that by 2050, 10 million deaths each year are possible due to antimicrobial resistance or AMR.


Bandung Declares Flood Emergency Until January 20

15 Januari 2024

Bandung Declares Flood Emergency Until January 20

The Bandung district government, West Java, has declared an flood emergency response status from January 13 to January 20, 2024.


Depok Records 200% Hike in COvid-19 Cases Last December

3 Januari 2024

Depok Records 200% Hike in COvid-19 Cases Last December

Depok Mayor Mohammad Idris revealed that the number of Covid-19 cases in the city surged from 100 to 300 as of December 2023


Indonesia Still Provides Free COVID-19 Vaccines for 2 Vulnerable Groups

2 Januari 2024

Indonesia Still Provides Free COVID-19 Vaccines for 2 Vulnerable Groups

Indonesia's Health Ministry has announced that COVID-19 vaccines would remain free of charge for two vulnerable groups starting from January 1, 2024.


Self-paid COVID-19 Vaccination Program to Start in 2024

28 Desember 2023

Self-paid COVID-19 Vaccination Program to Start in 2024

The Jakarta Health Agency is set to begin implementing the self-paid COVID-19 vaccination starting January 1, 2024.